Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Contemp Nurse ; 49: 83-92, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25549748

RESUMEN

BACKGROUND: The microbiology component of Australian undergraduate nursing programmes varies considerably. Any actual or potential impact of this variation on infection control practice, as a nursing graduate, is relatively unknown. AIMS: The aim of this study was to explore infection control professionals' perceptions of the importance of microbiology and infection control training in undergraduate nursing curricula and the perceived retention of that knowledge and its transferability to practice. METHOD: Semi-structured interviews were conducted with eight infection control professionals from a range of hospital settings in Australia. FINDINGS: Four main themes emerged: Theory versus practice, importance of role modelling, disjunction between university curricula and 'the real world,' and learning in context. CONCLUSION: As the underpinning element of infection control practice, the role of microbiology education and training in nursing education will benefit from review. Further discussions about the nature and timing of theoretical microbiology content and assessment of undergraduate students' microbiology knowledge to ensure retention and appropriate application of that knowledge in practice are urgently needed.


Asunto(s)
Bachillerato en Enfermería/organización & administración , Control de Infecciones , Conocimiento , Personal de Enfermería/psicología , Curriculum , Humanos , Nueva Gales del Sur
2.
Vet Microbiol ; 155(1): 33-7, 2012 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-21924564

RESUMEN

Two known serotypes of equine adenovirus (EAdV), equine adenovirus type 1 (EAdV-1) and equine adenovirus type 2 (EAdV-2) have been isolated from horses. EAdV-1 is predominantly associated with upper respiratory tract infections while EAdV-2 appears to be associated with gastrointestinal infections in horses. In this report the EAdV-1 genome has been sequenced for the first time. The EAdV-1 genome encoded genes are characteristic of the Mastadenovirus genus such as protein V and IX. Unexpectedly, phylogenetic reconstructions also revealed a close relationship between EAdV-1 and two recently characterized bat adenoviruses. The results of this study suggest that EAdV-1 may share a common ancestor with canine and bat adenoviruses.


Asunto(s)
Infecciones por Adenoviridae/veterinaria , Adenoviridae/clasificación , Adenoviridae/genética , Genoma Viral/genética , Enfermedades de los Caballos/virología , Filogenia , Infecciones por Adenoviridae/virología , Animales , Secuencia de Bases , Caballos , Mastadenovirus/clasificación , Mastadenovirus/genética
3.
Eur J Pharm Sci ; 30(5): 398-405, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17275269

RESUMEN

UNLABELLED: We aimed to increase the efficiency of adenoviral vectors by limiting adenoviral spread from the target site and reducing unwanted host immune responses to the vector. We complexed adenoviral vectors with DDAB-DOPE liposomes to form adenovirus-liposomal (AL) complexes. AL complexes were delivered by intratumoral injection in an immunocompetent subcutaneous rat tumor model and the immunogenicity of the AL complexes and the expression efficiency in the tumor and other organs was examined. Animals treated with the AL complexes had significantly lower levels of beta-galactosidase expression in systemic tissues compared to animals treated with the naked adenovirus (NA) (P<0.05). The tumor to non-tumor ratio of beta-galactosidase marker expression was significantly higher for the AL complex treated animals. NA induced significantly higher titers of adenoviral-specific antibodies compared to the AL complexes (P<0.05). The AL complexes provided protection (immunoshielding) to the adenovirus from neutralizing antibody. Forty-seven percent more beta-galactosidase expression was detected following intratumoral injection with AL complexes compared to the NA in animals pre-immunized with adenovirus. CONCLUSIONS: Complexing of adenovirus with liposomes provides a simple method to enhance tumor localization of the vector, decrease the immunogenicity of adenovirus, and provide protection of the virus from pre-existing neutralizing antibodies.


Asunto(s)
Adenoviridae/metabolismo , Vectores Genéticos/metabolismo , Liposomas , Fosfatidiletanolaminas/química , Compuestos de Amonio Cuaternario/química , Neoplasias de las Glándulas Salivales/metabolismo , Transducción Genética/métodos , Adenoviridae/genética , Adenoviridae/inmunología , Animales , Formación de Anticuerpos , Línea Celular Tumoral , Genes Reporteros , Vectores Genéticos/inmunología , Humanos , Conformación Molecular , Tamaño de la Partícula , Ratas , Neoplasias de las Glándulas Salivales/genética , Neoplasias de las Glándulas Salivales/inmunología , Distribución Tisular , beta-Galactosidasa
4.
Parasitol Res ; 99(6): 722-8, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16741725

RESUMEN

Two essential oils derived from Lavandula angustifolia and Lavandula x intermedia were investigated for any antiparasitic activity against the human protozoal pathogens Giardia duodenalis and Trichomonas vaginalis and the fish pathogen Hexamita inflata: all of which have significant infection and economic impacts. The study has demonstrated that low (< or = 1%) concentrations of L. angustifolia and L. x intermedia oil can completely eliminate T. vaginalis, G. duodenalis and H. inflata in vitro. At 0.1% concentration, L. angustifolia oil was found to be slightly more effective than L x intermedia oil against G. duodenalis and H. inflata. The potential applications are discussed.


Asunto(s)
Antiprotozoarios/farmacología , Diplomonadida/efectos de los fármacos , Aceites Volátiles/farmacología , Trichomonas vaginalis/efectos de los fármacos , Animales , Antiprotozoarios/farmacocinética , Antitricomonas/farmacología , Giardia lamblia/efectos de los fármacos , Lavandula/química , Aceites Volátiles/farmacocinética , Aceites de Plantas/farmacología
5.
Phytother Res ; 19(7): 643-6, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16161028

RESUMEN

To date, of the Australian essential oils, only tea tree (Melaleuca alternifolia) and Eucalyptus spp. have undergone extensive investigation. In this study a range of Australian essential oils, including those from Anethole anisata, Callistris glaucophyllia, Melaleuca spp. and Thyptomine calycina, were assayed for in vitro antibacterial activity. M. alternifolia was also included for comparison purposes. Activity was determined using standard disc diffusion assays with each oil assayed at 100%, 10% and 1% against five bacteria (Escherichia coli, Salmonella typhimurium, Staphylococcus aureus, Pseudomonas aeruginosa and Alcaligenes faecalis) and the yeast, Candida albicans. All bacteria, with the exception of Ps. aeruginosa, were susceptible to one or more of the essential oils at 100%, with only Eremophilia mitchelli inhibiting the growth of any bacteria at 1% (inhibition of Sal. typhimurium). Where multiple samples of a single oil variety were tested variability in activity profiles were noted. This suggests that different methods of preparation of essential oils, together with variability in plant chemical profiles has an impact on whether or not the essential oil is of use as an antimicrobial agent. These results show that essential oils from Australian plants may be valuable antimicrobial agents for use alone or incorporated into cosmetics, cleaning agents and pharmaceutical products.


Asunto(s)
Antibacterianos/farmacología , Fitoterapia , Aceites de Plantas/farmacología , Plantas Medicinales , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Australia , Candida albicans/efectos de los fármacos , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Aceites de Plantas/administración & dosificación , Aceites de Plantas/uso terapéutico , Aceite de Árbol de Té/administración & dosificación , Aceite de Árbol de Té/farmacología , Aceite de Árbol de Té/uso terapéutico
6.
J Virol Methods ; 126(1-2): 31-6, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15847916

RESUMEN

Adenoviral vectors have been commonly used in gene therapy protocols, however the success of their use is often limited by the induction of host immunity to the vector. Following exposure to the adenoviral vector, adenoviral-specific neutralising antibodies are produced which limits further administration. This study examines the efficacy of complexing liposomes to adenovirus for the protection of the adenovirus from neutralising antibodies in an in vitro setting. Dimethyldioctadecylammonium bromide (DDAB)-dioleoyl-l-phosphatidylethanolamine (DOPE) liposomes were bound at varying concentrations to adenovirus to form AL complexes and tested these complexes' ability to prevent adenoviral neutralisation. It is shown that by increasing the concentration of liposomes in the adenoviral-liposome (AL) complexes we can increase the level of immuno-shielding afforded the adenovirus. It is also shown that the increase in liposomal concentration may lead to drawbacks such as increased cytotoxicity and reductions in expression levels.


Asunto(s)
Adenoviridae/química , Adenoviridae/inmunología , Vectores Genéticos/química , Vectores Genéticos/inmunología , Liposomas/inmunología , Pruebas de Neutralización , Línea Celular , Expresión Génica , Genes Reporteros , Humanos , Liposomas/química , Liposomas/toxicidad , Fosfatidiletanolaminas/química , Fosfatidiletanolaminas/inmunología , Compuestos de Amonio Cuaternario/química , Compuestos de Amonio Cuaternario/inmunología , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismo
7.
J Med Food ; 8(1): 100-3, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15857217

RESUMEN

In this study the activity of 13 honeys, including three commercial antibacterial honeys, against Escherichia coli and Pseudomonas aeruginosa was determined. Antibacterial activity of the honeys was assayed using standard well diffusion methods. All honeys, and an artificial honey, were tested at four concentrations (10%, 5%, 2.5%, and 1% wt/vol) against E. coli and P. aeruginosa, and zones of inhibition were measured. All honeys tested had an inhibitory effect on the growth of E. coli and P. aeruginosa, with one honey still having activity against E. coli and three having activity against P. aeruginosa at 2.5%. No honey was active at 1% concentrations. E. coli was more susceptible to inhibition by the honeys used in this study than was P. aeruginosa. In this study we have demonstrated that several honeys, in addition to commercial antibacterial honeys, can inhibit E. coli and P. aeruginosa and may have potential as therapeutic honeys.


Asunto(s)
Antibacterianos/farmacología , Escherichia coli/efectos de los fármacos , Miel , Pseudomonas aeruginosa/efectos de los fármacos , Recuento de Colonia Microbiana , Relación Dosis-Respuesta a Droga , Escherichia coli/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana , Pseudomonas aeruginosa/crecimiento & desarrollo
8.
J Pharm Pharmacol ; 56(11): 1371-8, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15525443

RESUMEN

Adenoviral vectors have been commonly used in gene therapy protocols but the success of their use is often limited by the induction of host immunity to the vector. Following exposure to the adenoviral vector, adenoviral-specific neutralising antibodies are produced, which limits further administration. This study examines the effectiveness of a novel combination of microspheres and liposomes for the shielding of adenovirus from neutralising antibodies in an in-vitro setting. We show that liposomes are effective in the protection of adenovirus from neutralising antibody and that the conjugation of these complexes to microspheres augments the level of protection. This study further reveals that previously neutralised adenovirus may still be transported into the cell via liposome-cell interactions and is still capable of expressing its genes, making this vector an effective tool for circumvention of the humoral immune response. We also looked at possible side effects of using the complexes, namely increases in cytotoxicity and reductions in transfection efficiency. Our results showed that varying the liposome:adenovirus ratio can reduce the cytotoxicity of the vector as well as increase the transfection efficiency. In addition, in cell lines that are adenoviral competent, transfection efficiencies on par with uncomplexed adenoviral vectors were achievable with the combination vector.


Asunto(s)
Adenoviridae/genética , Terapia Genética/métodos , Vectores Genéticos , Adenoviridae/inmunología , Adenoviridae/metabolismo , Formación de Anticuerpos , Muerte Celular , Sistemas de Liberación de Medicamentos , Células HeLa , Humanos , Liposomas , Microesferas , Transfección
9.
J Control Release ; 95(3): 601-11, 2004 Mar 24.
Artículo en Inglés | MEDLINE | ID: mdl-15023470

RESUMEN

This study looks at the development of a novel combination vector consisting of adenovirus conjugated to liposomes (AL complexes) bound to cation-exchanging microspheres (MAL complexes). With adenovirus having a net negative charge and the liposomes a net positive charge it was possible to modify the net charge of the AL complexes by varying the concentrations of adenovirus to liposomes. The modification of the net charge resulted in altered binding and release characteristics. Of the complexes tested, the 5:1 and 2:1 ratio AL complexes were able to be efficiently bound by the microspheres and exhibited sustained release over 24 h. The 1:1 and 1:2 AL complexes, however, bound poorly to the microspheres and were rapidly released. In addition the MAL complexes also were able to reduce the toxicity of the AL complexes, which was seen with the 10:1 ratio. The AL complexes showed considerably more toxicity alone than in combination with microspheres, highlighting a potential benefit of this vector.


Asunto(s)
Adenoviridae/metabolismo , Evaluación Preclínica de Medicamentos/métodos , Resinas de Intercambio Iónico/farmacocinética , Liposomas/farmacocinética , Microesferas , Adenoviridae/química , Adenoviridae/genética , Administración Tópica , Animales , Preparaciones de Acción Retardada/farmacocinética , Expresión Génica , Terapia Genética/métodos , Células HeLa , Humanos , Resinas de Intercambio Iónico/química , Liposomas/química , Ratas , beta-Galactosidasa/biosíntesis , beta-Galactosidasa/genética
10.
Cancer Ther ; 2: 239-244, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-18587499

RESUMEN

Successful liposomal-mediated gene therapy is often limited by poor transfection efficiencies. One method previously shown to increase the efficiency of liposomal gene delivery is through the administration of a non-therapeutic dose of the chemotherapeutic drug cisplatin prior to lipofection. The currents study aims to utilise this method to deliver lipoplexes containing the p53 tumour suppressor gene with the aim of increasing therapeutic effect of the p53 gene on a solid tumour in vivo. Rats, implanted with solid salivary adenocarcinomas, were pre-treated with a low dose of cisplatin seven days prior to liposomal mediated p53 treatment. Following treatment with p53, tumour growth, p53 expression and levels of apoptosis were examined and compared to animals treated with p53 without cisplatin pre-treatment and a saline control. Tumours that had been pre-treated with cisplatin prior to p53-lipofection were significantly smaller than both the saline control and the non-cisplatin treated tumours. Saline treated tumours increased in size by an average of 164% over a 96-hour period compared to 64% and 101% for the cisplatin and non-cisplatin p53-liposome treated tumours. The cisplatin pre-treated tumours resulted in significantly higher levels of apoptosis surrounding the treatment site and exhibited prolonged p53 expression when compared to the non-cisplatin pre-treated tumours. The results suggest that the use of cisplatin to pre-sensitise tumours to lipofection has significant benefits when used in conjunction with p53.

11.
J Med Food ; 6(1): 57-61, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12804021

RESUMEN

Increasing interest in the health benefits of various culinary berries has led to investigation of their antibacterial activity. Commercial raspberry, blackcurrant, cranberry, and blackberry cordials (100% fruit) as well as fresh berries were assessed for their ability to inhibit the growth of various bacteria and the yeast Candida albicans. Three of the six raspberry cordials and the blackcurrant cordial inhibited all 12 bacteria and C. albicans at dilutions of 1:5. Bacteria showed varying susceptibilities to the remaining cordials. All cordials inhibited the growth of Mycobacterium phlei. Of the fresh berries, mulberries and boysenberries did not inhibit any bacteria, and the remaining berries inhibited the growth of varying numbers of bacteria. There was no correlation between gram-positive or gram-negative bacterial status and susceptibility to the berries. It is suggested that the antibacterial activity of these berries may be of benefit as a means of water purification for suspect water supplies or to enhance shelf life when incorporated into food products.


Asunto(s)
Antiinfecciosos , Frutas , Antibacterianos , Bacterias , Bebidas , Candida albicans , Frutas/química , Mycobacterium phlei , Ribes , Rosácea , Vaccinium macrocarpon
12.
J Agric Food Chem ; 51(1): 76-81, 2003 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-12502388

RESUMEN

Backhousia citriodora products are used as bushfoods and flavorings and by the aromatherapy industry. The antimicrobial activity of 4 samples of B. citriodora oil, leaf paste, commercial tea (0.2 and 0.02 g/mL), and hydrosol (aqueous distillate) were tested against 13 bacteria and 8 fungi. Little or no activity was found to be associated with the leaf tea and hydrosol, respectively. Leaf paste displayed antimicrobial activity against 7 bacteria including Clostridium perfringens, Pseudomonas aeruginosa, and a hospital isolate of methicillin resistant Staphylococcus aureus (MRSA). The 4 essential oils were found to be effective antibacterial and antifungal agents; however, variation was apparent between oils that did not correlate with citral content. The antimicrobial activity of B. citriodoraessential oils was found to be greater than that of citral alone and often superior to Melaleuca alternifolia essential oil. B. citriodora has significant antimicrobial activity that has potential as an antiseptic or surface disinfectant or for inclusion in foods as a natural antimicrobial agent.


Asunto(s)
Antibacterianos/farmacología , Antifúngicos/farmacología , Myrtaceae/química , Aceites Volátiles/farmacología , Hojas de la Planta/química , Antibacterianos/análisis , Antifúngicos/análisis , Bebidas/análisis , Clostridium perfringens/efectos de los fármacos , Extractos Vegetales/farmacología , Pseudomonas aeruginosa/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Aceite de Árbol de Té/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA